Innovation competition of the German government for digital identity wallets enters final round with Lissi GmbH
Berlin, 11.12.2024 - Lissi GmbH has qualified for the final phase of the EUDI-Wallet prototype competition organised by the German Federal Agency for Leap Innovation (SPRIND). The competition promotes innovative solutions for the implementation of the European eIDAS 2.0 regulation.
“We are proud to have once again convinced the jury and to be part of such a prestigious programme. We would like to express our gratitude to the Federal Ministry of the Interior and Community and SPRIND for the professional and transparent organisation of the competition and the public consultation process. The international attention for the German approach underlines its character as a role model in Europe”, says Helge Michael, co-founder and CEO of Lissi.
Lissi specialises in the development of the EUDI-Wallet Connector, an application that enables organisations to interact seamlessly with the German EUDI-Wallet and all future certified wallets in Europe. The focus is on supporting regulated sectors such as banking, insurance and telecommunications as well as the public administration. The connector enables the issuance and verification of digital credentials, making it easier for organisations to comply with regulatory requirements and use digital wallets efficiently.
The German Wallet, announced for 2025, will for the first time allow citizens to carry their ID card securely and digitally on a mobile device. Lissi is already enabling organisations to prepare for the connection and integration.
"The participation of Samsung and Google in the challenge underlines the global strategic importance of our work," adds Helge Michael.
With the EUDI-Wallet Connector, Lissi ensures that organisations are prepared for the requirements of the eIDAS 2.0 regulation and the megatrend of digital trust with identity wallets. For further information please visit the Lissi website.
Contact:
info@lissi.id
Lissi GmbH
Eschersheimer Landstraße 6
60322 Frankfurt am Main
Germany
Nyckelord
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
Följ news aktuell GmbH
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från news aktuell GmbH
FEV develops AI-supported driver monitoring system CogniSafe9.1.2025 11:00:00 CET | Pressmeddelande
Aachen – FEV, a leading global innovation driver for the mobility of tomorrow, presents CogniSafe, a state-of-the-art Driver Monitoring System (DMS) that significantly increases road safety. The system uses advanced technologies such as deep learning and computer vision to monitor driver conditions such as distraction, fatigue and inattention in real time and under even the most challenging conditions.
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer9.1.2025 10:25:56 CET | Press Release
Aachen, Germany, 09 January 2025 – Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025. Uli Brödl has more than 15 years of industry experience. He joins Grünenthal from Boehringer Ingelheim, where he served as Corporate Senior Vice President, Head of Global Clinical Development & Operations, and member of Boehringer Ingelheim's Venture Fund Investment Committee. In his most recent role, he oversaw end-to-end clinical development and operations activities across therapeutic areas and worked at the interface of R&D, Commercial, and Market Access functions. He has a proven track record of bringing innovative medicines to patients, including Empagliflozin, an oral anti-diabetic medicine. Earlier in his career, Uli Brödl led Boehringer Ingelheim's Canadian medical organisation and gained extensive market experience. In parallel, he founded and co-chaired the BI Can
175 years of Heidelberger Druckmaschinen: Company starts anniversary year with growth strategy8.1.2025 13:11:11 CET | Press Release
Growth strategy: medium-term sales potential of more than € 300 million Growth drivers in the core business: packaging, digital printing Software and lifecycle business Industrial business: focus on further expansion 175 years: the company has been shaping the printing industry for decades with technological innovations, quality and reliability Numerous anniversary activities throughout the year
Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality7.1.2025 08:16:33 CET | Press Release
As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe.
SNP expands partnership with SAP7.1.2025 08:07:10 CET | Press Release
Long-standing partnership as strong foundation for extended collaboration Expanded cooperation in global RISE with SAP transformation projects Joint initiative to develop data migration and conversion scenarios for public cloud solutions
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.
Besök vårt pressrum